Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of quetiapine fumarate
extended-release (XR) used as mono-therapy, administered once daily, in the treatment of
schizophrenic patient with acute episode.